163 related articles for article (PubMed ID: 7996467)
1. The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.
Cleary J; Mikus G; Somogyi A; Bochner F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1528-34. PubMed ID: 7996467
[TBL] [Abstract][Full Text] [Related]
2. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine.
Beaver WT; Wallenstein SL; Rogers A; Houde RW
J Pharmacol Exp Ther; 1978 Oct; 207(1):101-8. PubMed ID: 359778
[TBL] [Abstract][Full Text] [Related]
3. Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphism.
Mikus G; Bochner F; Eichelbaum M; Horak P; Somogyi AA; Spector S
J Pharmacol Exp Ther; 1994 Feb; 268(2):546-51. PubMed ID: 8113966
[TBL] [Abstract][Full Text] [Related]
4. Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer.
Susce MT; Murray-Carmichael E; de Leon J
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1356-8. PubMed ID: 16631290
[TBL] [Abstract][Full Text] [Related]
5. Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors.
Thompson CM; Wojno H; Greiner E; May EL; Rice KC; Selley DE
J Pharmacol Exp Ther; 2004 Feb; 308(2):547-54. PubMed ID: 14600248
[TBL] [Abstract][Full Text] [Related]
6. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat.
Nielsen CK; Ross FB; Smith MT
J Pharmacol Exp Ther; 2000 Oct; 295(1):91-9. PubMed ID: 10991965
[TBL] [Abstract][Full Text] [Related]
7. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
8. Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone.
Beaver WT; Wallenstein SL; Rogers A; Houde RW
J Pharmacol Exp Ther; 1978 Oct; 207(1):92-100. PubMed ID: 359779
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.
Peckham EM; Traynor JR
J Pharmacol Exp Ther; 2006 Mar; 316(3):1195-201. PubMed ID: 16291875
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
11. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.
Zwisler ST; Enggaard TP; Noehr-Jensen L; Pedersen RS; Mikkelsen S; Nielsen F; Brosen K; Sindrup SH
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):335-44. PubMed ID: 19281600
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
13. Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype.
Mikus G; Trausch B; Rodewald C; Hofmann U; Richter K; Gramatté T; Eichelbaum M
Clin Pharmacol Ther; 1997 Apr; 61(4):459-66. PubMed ID: 9129563
[TBL] [Abstract][Full Text] [Related]
14. Ethylmorphine O-deethylation in isolated rat hepatocytes. Involvement of codeine O-demethylation enzyme systems.
Xu BQ; Aasmundstad TA; Bjørneboe A; Christophersen AS; Mørland J
Biochem Pharmacol; 1995 Feb; 49(4):453-60. PubMed ID: 7872951
[TBL] [Abstract][Full Text] [Related]
15. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
[TBL] [Abstract][Full Text] [Related]
17. Thebaine O-demethylation to oripavine: genetic differences between two rat strains.
Mikus G; Somogyi AA; Bochner F; Eichelbaum M
Xenobiotica; 1991 Nov; 21(11):1501-9. PubMed ID: 1763524
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague--Dawley rats: influence of streptozotocin-induced diabetes.
Huang L; Edwards SR; Smith MT
Pharm Res; 2005 Sep; 22(9):1489-98. PubMed ID: 16132361
[TBL] [Abstract][Full Text] [Related]
19. Evidence for CYP2D1-mediated primary and secondary O-dealkylation of ethylmorphine and codeine in rat liver microsomes.
Xu BQ; Aasmundstad TA; Christophersen AS; Mørland J; Bjørneboe A
Biochem Pharmacol; 1997 Feb; 53(4):603-9. PubMed ID: 9105413
[TBL] [Abstract][Full Text] [Related]
20. Inducing rat brain CYP2D with nicotine increases the rate of codeine tolerance; predicting the rate of tolerance from acute analgesic response.
McMillan DM; Tyndale RF
Biochem Pharmacol; 2017 Dec; 145():158-168. PubMed ID: 28837793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
